Dianthus Therapeutics Inc
NASDAQ:DNTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dianthus Therapeutics Inc
NASDAQ:DNTH
|
US |
|
K
|
Kawasaki Kisen Kaisha Ltd
F:KLI
|
JP |
|
Ecora Royalties PLC
OTC:ECRAF
|
UK |
|
H
|
Hyprop Investments Ltd
JSE:HYP
|
ZA |
|
Sodexo SA
F:SJ7
|
FR |
|
A
|
Asiamet Resources Ltd
F:0FK
|
ID |
|
AAC Clyde Space AB
F:MKC0
|
SE |
|
Euro Manganese Inc
F:E06A
|
CA |
|
Amplifon SpA
MIL:AMP
|
IT |
|
B
|
BayCom Corp
F:B2J
|
US |
|
Grid Battery Metals Inc
OTC:EVKRF
|
CA |
|
A
|
AT & S Austria Technologie & Systemtechnik AG
XHAM:AUS
|
AT |
|
EKF Diagnostics Holdings PLC
F:LYF
|
UK |
|
P
|
Petroleo Brasileiro SA Petrobras
XMUN:PJXB
|
BR |
|
T
|
Turbon AG
SWB:TUR
|
DE |
|
B
|
Boe Varitronix Ltd
F:VTX
|
HK |
|
A
|
AT & S Austria Technologie & Systemtechnik AG
DUS:AUS
|
AT |
|
C
|
CenterPoint Energy Inc
XMUN:HOU
|
US |
|
Romerike Sparebank
F:92I
|
NO |
|
C
|
CenterPoint Energy Inc
DUS:HOU
|
US |
|
A
|
ATHA Energy Corp
OTC:SASKF
|
CA |
|
ATON Green Storage SpA
F:6E6
|
IT |
|
R
|
Rarex Ltd
F:CK1
|
AU |
|
N
|
Nomura Real Estate Master Fund Inc
OTC:NMMRF
|
JP |
Bankruptcy Probability
Dianthus Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dianthus Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Dianthus Therapeutics Inc
NASDAQ:DNTH
|
4.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dianthus Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dianthus Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.